CaSRevolution
A new hope for patients affected by Alzheimer’s disease
- Stage Product In Development
- Industry Biotechnology
- Location Milan, Metropolitan City of Milan, Italy
- Currency EUR
- Founded February 2019
- Employees 3
- Incorporation Type LLC
- Website casrevolution.com
Company Summary
CaSRevolution is a pharmaceutical company focused on the development of new therapeutic products for the treatment of Alzheimer’s disease (AD). We are now raising €2.5M at a €6M pre-money valuation. We have already the hard commitment of €1.2M
Team
-
Head of Drug Development
-
Head of Drug Discovery
Previous Investors
-
Luca BenattiUnconfirmedEnrico PandianUnconfirmedUtopia SisUnconfirmed
-
Elena ZambonUnconfirmed
-
Chiara ZambonUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.